Mahlzeiten für mich: Umgang mit Diabetes zu Hause
Lieferung von medizinisch maßgeschneiderten Mahlzeiten nach Hause zur Verbesserung des Diabetes-Managements
This is a three-arm, parallel randomized trial study that will assess the impact of home delivery of medically-tailored meals (MTM) to community-dwelling older adults living with diabetes mellitus type 2 on measurements of diabetes control, mental health, and other exploratory outcomes such as healthcare use.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
This study aims to:
- Assess the impact of medically-tailored meals program on diabetes management and mental health in comparison to usual care without such program.
- Assess the differential impact of two delivery models being considered for payment by the health system on diabetes management and mental health: once-a-week frozen drop shipment model versus daily warm meal delivery model that is more complex to implement but allows for human connection and easier meal preparation.
Implementation of program:
Meals on Wheels (MoW) of Central Texas (MOWCTX) in Austin, Texas, will provide the meals and delivery service in this study. Meals are all medically tailored (diabetes friendly) and design by MOWCT's team of Registered Dietitians.
Participants:
Older adults, 55 and over, living in the Austin city limits with poorly controlled diabetes; Inclusion criteria:
- Adult 55-90
- Hemoglobin A1C >=7.5 (as measured at baseline)
- Living in Austin city limits and within a MOWCTX daily delivery route
- Interested and available to receive meals during delivery window time
- Has access to a freezer and a microwave
- Pass a MOWCTX background check
Trial:
Eligible participants will be recruited from selected Federally Qualified Health Centers in the Austin area, MOWCTX clients on waitlist, and other (e.g. Medicaid recipients).
Participants will be randomized to one of three arms: 1) Waitlisted control; 2) Weekly frozen drop shipment of MTM 3) Daily Warm delivery of MTM with in-person check-ins during delivery.
Phase 1 (first 6 months) The intervention arms will receive their assigned method of meal delivery (weekly frozen or daily warm), for a total of 10 meals a week, including two main meals per day and snacks. The control arm will not receive any meals during this phase. All arms will receive printed educational materials at baseline.
Phase 2 (month 6 to 12) All arms will receive 2-4 meals a week (depending on participant's availability) delivered via the traditional meal services from MOWCTX, which includes one hot meal plus a snack delivered daily. Meal delivery can also include 1 or more frozen meals to account for a total of 5 meals per week.
Primary outcome is Hemoglobin A1C and secondary outcomes include depression as measured by PHQ-8 and other mental health measures.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
Texas
-
Austin, Texas, Vereinigte Staaten, 78702
- Meals on Wheels Central Texas
-
Austin, Texas, Vereinigte Staaten, 78741
- CommUnityCare Health Centers (all Austin clinics)
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Adult 55-90
- Hemoglobin A1c ≥7.5%
- Living in Austin city limits and within a MOWCTX daily delivery route
- Interested and available to receive meals during delivery window time
- Has access to a freezer and a microwave
- Pass a MOWCTX background check
Exclusion Criteria:
- Participated in MOW program in previous 3 months.
- Has any of the following: dementia or cognitive impairment, diagnosis of heart failure, cirrhosis, or active cancer
- Is receiving hospice care
- Does not pass a MOWCTX background check
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Versorgungsforschung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Doppelt
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Sonstiges: Waitlisted control
Phase 1 (6 months, months 1-6):
Phase 2 (6 months, months 7-12): Standard MOWCTX home meal delivery: 5 meals a week, delivered daily 2 to 4X a week |
Phase 1 (6 months) • Educational materials on such topics as healthy eating for diabetes. Phase 2 (6 months)
|
|
Experimental: "Daily Warm" MTM in-person delivery
Phase 1 (6 months, months 1-6):
Phase 2 (6 months, months 7-12): Standard MOWCTX home meal delivery: 5 meals a week, delivered daily 2 to 4X a week |
Phase 2 (6 months)
Phase 1 (6 months)
|
|
Experimental: "Weekly Frozen" MTM drop shipment
Phase 1 (6 months, months 1-6):
Phase 2 (6 months, months 7-12): Standard MOWCTX home meal delivery: 5 meals a week, delivered daily 2 to 4X a week. |
Phase 2 (6 months)
Phase 1 (6 months)
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Hemoglobin A1C (HbA1c)
Zeitfenster: Baseline to 6 months
|
Finger stick point-of-care portable device. |
Baseline to 6 months
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Hemoglobin A1C
Zeitfenster: Baseline to 9 &12 months, 6 months to 12 months.
|
Finger stick point-of-care portable device. |
Baseline to 9 &12 months, 6 months to 12 months.
|
|
Program meal consumption
Zeitfenster: 6 months, 12 months
|
For frozen and warm meals, self-report on what was actually consumed (customized survey) |
6 months, 12 months
|
|
Diet quality as assessed by NHANES DSQ
Zeitfenster: 6 months, 12 months
|
Self-report of food consumption patterns |
6 months, 12 months
|
|
Loneliness as assessed by scores on the 3-item UCLA Loneliness Scale
Zeitfenster: 6 months, 12 months
|
Respondents rate each item as 'Never' , 'Rarely', 'Sometimes' or 'Often'. Scores range from 3 to 9. Higher numbers imply greater loneliness. |
6 months, 12 months
|
|
Depressive symptoms as assessed by scores on the the 8-item Depression Health Questionnaire (PHQ-8)
Zeitfenster: 6 months, 12 months
|
Respondents answer to eight questions that reflect the DSM-IV diagnosis criteria of depressive disorders. These questions ask how often in the past 2 weeks the respondent had experienced a particular depressive symptom. Each answer is scored from 0 to 3 and then summed. Total scores go from 0 and 24 points, with higher scores indicating greater depressive symptoms. |
6 months, 12 months
|
|
Anxiety symptoms as assessed by the 7-item Generalized Anxiety Disorder Scale (GAD-7)
Zeitfenster: 6 months
|
Investigators will use the Generalized Anxiety Disorder Scale (GAD-7) to measure anxiety. Scored from 0-3, and a score of 0 indicates lower levels of anxiety while a score of 3 indicates higher levels of anxiety. |
6 months
|
|
Diabetes Self-Efficacy as assessed by scores on the Stanford Self-Efficacy for Diabetes Scale 8-item
Zeitfenster: 6 months, 12 months
|
Respondents are asked to score their level of confidence (scale from 1, not at all confident, to 10, totally confident) at the present time in doing tasks related to diabetes management (e.g., diet behavior, physical activity, measuring blood glycemia and others). Higher scores indicate higher self-efficacy. |
6 months, 12 months
|
|
Food security status as assessed by the USDA Food Security Survey Module: Six-Item Short Form
Zeitfenster: 6 months, 12 months
|
Self-reported with a 30-day lookback period. The sum of affirmative responses to the six questions in the module is the household's raw score on the scale. Higher scores indicate greater food insecurity. |
6 months, 12 months
|
|
Health Status and Quality of Life as assessed by scores on Short-form 12-item (SF-12)
Zeitfenster: 6 months, 12 months
|
Measures physical and mental health status. Summary scores range from 0-100, with higher scores indicating a better self-reported level of health. |
6 months, 12 months
|
|
Healthcare delay due to cost
Zeitfenster: 6 months, 12 months
|
Self-report of delaying healthcare due to cost. 1 item. |
6 months, 12 months
|
|
Emergency room visits
Zeitfenster: 6 months, 12 months
|
Self-report of going to a hospital emergency room. |
6 months, 12 months
|
|
Food-basic needs trade-offs (3 items)
Zeitfenster: 6 months, 12 months
|
Self-report of trading off paying for food vs. paying for medicine or medical care, for utilities, and for housing |
6 months, 12 months
|
|
Medication underuse due to cost (2 items)
Zeitfenster: 6 months, 12 months
|
Self-report of not acquiring a prescribed medication or took reduce dosage due to cost. |
6 months, 12 months
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Hauptermittler: Maninder K Kahlon, PhD, University of Texas at Austin
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des endokrinen Systems
- Pathologische Prozesse
- Krankheitsattribute
- Stoffwechselerkrankungen
- Störungen des Glukosestoffwechsels
- Pathologische Zustände, Anzeichen und Symptome
- Ernährungs- und Stoffwechselerkrankungen
- Diabetes Mellitus
- Chronische Erkrankung
- Organisation und Verwaltung
- Verwaltung des Gesundheitswesens
- Termine und Zeitpläne
- Wartelisten
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- STUDY00002808-2022
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .